Ligand Pharmaceuticals
LGND
LGND
241 hedge funds and large institutions have $2.27B invested in Ligand Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 80 increasing their positions, 94 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
23% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 40
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
81% less call options, than puts
Call options by funds: $33.1M | Put options by funds: $173M
Holders
241
Holding in Top 10
2
Calls
$33.1M
Puts
$173M
Top Buyers
| 1 | +$19.3M | |
| 2 | +$17.1M | |
| 3 | +$16.4M | |
| 4 |
CCMLC
Cardinal Capital Management LLC (Connecticut)
Greenwich,
Connecticut
|
+$14.6M |
| 5 |
William Blair Investment Management
Chicago,
Illinois
|
+$14.5M |
Top Sellers
| 1 | -$25.1M | |
| 2 | -$16.9M | |
| 3 | -$15.2M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$12.8M |
| 5 |
Two Sigma Advisers
New York
|
-$11.3M |